Proteonomix, Inc. (PROT.OB), is a biotechnology company is dedicated to the development of therapeutics based on the use of human cells and their derivatives. Headquartered in Mountainside, New Jersey, Proteonomix has been working for almost a decade with leading scientists and universities, researching the potentials and therapeutics of stem cells to treat a broad array of diseases.
Proteoderm, Inc is a wholly-owned subsidiary of Proteonomix, Inc., formally National Stem Cell, Inc.
Proteoderm, Inc has developed a line of anti-aging skin care cosmetics based on stem cell derivatives. Proteoderm is the first company to use a matrix of proteins originally derived from non-embryonic stem cells, Matrix NC-138, to harness the anti-aging potential of stem cells in cosmeceutical products. Proteoderm does not use enzymes, collagen or growth factors which are the ingredients of other anti-aging cosmeceuticals and Proteoderm does not utilize embryonic stem cells as a source for its anti-aging skin care products.
Nu Skin Enterprises, Inc. (NYSE:NUS) has declared a quarterly dividend of $0.125 per share, which will be paid on Sept. 15, 2010, to stockholders of record on Aug. 27, 2010.
Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin’s scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC science that addresses the sources of aging. The company’s anti-aging products feature the new ageLOC family of skin care products including ageLOC Future Serum and the ageLOC Edition Galvanic Spa System II, as well as Tru Face Essence Ultra and LifePak Nano. A global direct selling company, Nu Skin operates in 50 markets worldwide and has more than 785,000 independent sales representatives.
Sally Beauty Holdings, Inc. (NYSE:SBH) reported strong financial results for the fiscal 2010 third quarter. The Company will hold a conference call today at 10:00 a.m. (Central) to discuss these results and its business.
Consolidated net sales for the fiscal 2010 third quarter were $743.0 million, an increase of 10.3% from the fiscal 2009 third quarter. Same store sales in the fiscal 2010 third quarter grew 4.6% compared to 2.6% in the fiscal 2009 third quarter. Net earnings(1) in the fiscal 2010 third quarter were $41.1 million; growth of 30.6% over GAAP net earnings of $31.5 million in the fiscal 2009 third quarter and growth of 37.1% over adjusted net earnings of $30.0 million in the fiscal 2009 third quarter. Diluted earnings per share (1) in the fiscal 2010 third quarter were $0.22; growth of 29.4% over GAAP diluted earnings per share of $0.17 and growth of 37.5% over adjusted diluted earnings per share of $0.16 in the fiscal 2009 third quarter. Adjusted EBITDA increased 12.9% in the fiscal 2010 third quarter to $107.8 million versus $95.5 million in the fiscal 2009 third quarter. Total store count at the end of the fiscal 2010 third quarter was 3,986, an increase of 165 stores or growth of 4.3% over the fiscal 2009 third quarter.
Sally Beauty Holdings, Inc. is an international specialty retailer and distributor of professional beauty supplies with revenues of more than $2.6 billion annually. Through the Sally Beauty Supply and Beauty Systems Group businesses, the Company sells and distributes through over 3,900 stores, including approximately 200 franchised units, throughout the United States, the United Kingdom, Belgium, Chile, France, Canada, Puerto Rico, Mexico, Ireland, Spain and Germany.
No comments:
Post a Comment